Citation Impact
Citing Papers
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
2012 StandoutScience
Sleep Drives Metabolite Clearance from the Adult Brain
2013 StandoutScience
Prion-like Properties of Tau Protein: The Importance of Extracellular Tau as a Therapeutic Target
2014
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
2009
Therapeutic strategies for tau mediated neurodegeneration
2012
Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
2009
Restricted and Regulated Overexpression Reveals Calcineurin as a Key Component in the Transition from Short-Term to Long-Term Memory
1998 StandoutNobel
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
2016 StandoutNature
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Insights into α1 adrenoceptor function in health and disease from transgenic animal studies
2003
The Transcellular Spread of Cytosolic Amyloids, Prions, and Prionoids
2009
Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo
2013
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Combined cholinergic and serotonergic denervation of the forebrain produces severe deficits in a spatial learning task in the rat
1988
Seeding of Normal Tau by Pathological Tau Conformers Drives Pathogenesis of Alzheimer-like Tangles
2011
Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval
2000 StandoutNature
High-resolution crystal structure of human protease-activated receptor 1
2012 StandoutNatureNobel
Development and validation of brief measures of positive and negative affect: The PANAS scales.
1988 Standout
apoE isoform–specific disruption of amyloid β peptide clearance from mouse brain
2008
Genetic and Pharmacological Evidence for a Novel, Intermediate Phase of Long-Term Potentiation Suppressed by Calcineurin
1998 StandoutNobel
Retrieval and Reconsolidation: Toward a Neurobiology of Remembering
2000
The adolescent brain and age-related behavioral manifestations
2000 Standout
Common method biases in behavioral research: A critical review of the literature and recommended remedies.
2003 Standout
Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer‘s disease
2014
Enhancement of Memory-Related Long-Term Facilitation by ApAF, a Novel Transcription Factor that Acts Downstream from Both CREB1 and CREB2
2000 StandoutNobel
Tau in physiology and pathology
2015 Standout
Aplysia CREB2 represses long-term facilitation: Relief of repression converts transient facilitation into long-term functional and structural change
1995 StandoutNobel
The CaM kinase II hypothesis for the storage of synaptic memory
1994
CaMKII regulates the frequency-response function of hippocampal synapses for the production of both LTD and LTP
1995 StandoutNobel
The Future of Memory: Remembering, Imagining, and the Brain
2012 StandoutNobel
Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice
2013
Autophagy in Human Health and Disease
2013 Standout
Rethinking schizophrenia
2010 StandoutNature
Recognition of Conserved Amino Acid Motifs of Common Viruses and Its Role in Autoimmunity
2005 StandoutNobel
Narcolepsy in orexin Knockout Mice
1999 Standout
Tau Immunotherapy and Imaging
2013
Alzheimer's disease
2006 Standout
Antibody Uptake into Neurons Occurs Primarily via Clathrin-dependent Fcγ Receptor Endocytosis and Is a Prerequisite for Acute Tau Protein Clearance
2013
The propagation of prion-like protein inclusions in neurodegenerative diseases
2010
cAMP contributes to mossy fiber LTP by initiating both a covalently mediated early phase and macromolecular synthesis-dependent late phase
1994 StandoutNobel
Histological Staining of Amyloid and Pre-amyloid Peptides and Proteins in Mouse Tissue
2012
The Role of Apolipoprotein E in Alzheimer's Disease
2009
Alzheimer's Disease
2010 Standout
Subregion- and Cell Type–Restricted Gene Knockout in Mouse Brain
1996 StandoutNobel
The lateral hypothalamic area revisited: Ingestive behavior
1996
C/EBP is an immediate-early gene required for the consolidation of long-term facilitation in Aplysia
1994 StandoutNobel
Injection of the cAMP-responsive element into the nucleus of Aplysia sensory neurons blocks long-term facilitation
1990 StandoutNatureNobel
Heavy-Chain Complementarity-Determining Regions Determine Conformation Selectivity of Anti-Aβ Antibodies
2010
Apolipoprotein E as a Therapeutic Target in Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence
2016
In VivoMicrodialysis Reveals Age-Dependent Decrease of Brain Interstitial Fluid Tau Levels in P301S Human Tau Transgenic Mice
2011
Transmission and spreading of tauopathy in transgenic mouse brain
2009
Passive Immunization with Tau Oligomer Monoclonal Antibody Reverses Tauopathy Phenotypes without Affecting Hyperphosphorylated Neurofibrillary Tangles
2014
Activation of cAMP-Responsive genes by stimuli that produce long-term facilitation in aplysia sensory neurons
1993 StandoutNobel
Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis
2006
From inflammation to sickness and depression: when the immune system subjugates the brain
2007 Standout
Lysosome-targeting chimaeras for degradation of extracellular proteins
2020 StandoutNatureNobel
The molecular neurobiology of depression
2008 StandoutNature
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
2017 Standout
Genetic Demonstration of a Role for PKA in the Late Phase of LTP and in Hippocampus-Based Long-Term Memory
1997 StandoutNobel
MAP Kinase Translocates into the Nucleus of the Presynaptic Cell and Is Required for Long-Term Facilitation in Aplysia
1997 StandoutNobel
Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway
1999 StandoutNobel
Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory
1998 StandoutNobel
KINETICS OF MEMORY CONSOLIDATION: ROLE OF AMNESIC TREATMENT PARAMETERS
1969
The long and the short of long–term memory—a molecular framework
1986 StandoutNatureNobel
A selective role of calcineurin Aα in synaptic depotentiation in hippocampus
1999 StandoutNobel
Lecanemab in Early Alzheimer’s Disease
2022 Standout
Capture of a protein synthesis-dependent component of long-term depression
2000 StandoutNobel
Time-Dependent Processes in Memory Storage
1966 Science
Memory--a Century of Consolidation
2000 StandoutScience
Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance
2011
Long-Term Potentiation--A Decade of Progress?
1999 StandoutScience
Immunotherapy Targeting Pathological Tau Protein in Alzheimer's Disease and Related Tauopathies
2008
Nervous system distribution of the serotonin 5-HT3 receptor mRNA.
1993 StandoutNobel
Myocyte Adrenoceptor Signaling Pathways
2003 StandoutScienceNobel
Sodium and Potassium
2009
Smoking and its effects on body weight and the systems of caloric regulation
1982
Memory consolidation: Further evidence for the four-phase model from the time-courses of diethyldithiocarbamate and ethacrinic acid amnesias
1982
Control of Memory Formation Through Regulated Expression of a CaMKII Transgene
1996 StandoutScienceNobel
The involvement of the locus coeruleus in memory
1981
A Bridge Over Troubled Water: Reconsolidation as a Link Between Cognitive and Neuroscientific Memory Research Traditions
2009
Repeated pulses of serotonin required for long-term facilitation activate mitogen-activated protein kinase in sensory neurons of Aplysia
1998 StandoutNobel
Afferent connections to the lateral hypothalamus: A horseradish peroxidase study in the rat
1981
The Cholinergic Hypothesis of Geriatric Memory Dysfunction
1982 StandoutScience
Retrograde Amnesia Produced by Electroconvulsive Shock after Reactivation of a Consolidated Memory Trace
1968 Science
Toward a molecular definition of long-term memory storage
1996 StandoutNobel
Protein synthesis and memory: A review.
1984
Tau Passive Immunotherapy in Mutant P301L Mice: Antibody Affinity versus Specificity
2013
Negative affectivity: The disposition to experience aversive emotional states.
1984 Standout
Works of David Quartermain being referenced
Pharmacological evidence for the role of central alpha 1B-adrenoceptors in the motor activity and spontaneous movement of mice
2001
Acute but not chronic activation of the NMDA-coupled glycine receptor with D-cycloserine facilitates learning and retention
1994
Vaccination of Alzheimer's model mice with Aβ derivative in alum adjuvant reduces Aβ burden without microhemorrhages
2006
Immunotherapy Targeting Pathological Tau Conformers in a Tangle Mouse Model Reduces Brain Pathology with Associated Functional Improvements
2007
Role of epinephrine stimulation of CNS α1‐adrenoceptors in motor activity in mice
2003
Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model
2010
Links Between the Pathology of Alzheimer's Disease and Vascular Dementia
2004
Pharmacological blockade of brain α1-adrenoceptors as measured by ex vivo [3H]prazosin binding is correlated with behavioral immobility
2001
Brain alpha 1-adrenergic neurotransmission is necessary for behavioral activation to environmental change in mice
1999
Amphetamine enhances retrieval following diverse sources of forgetting
1988
Greater Behavioral Effects of Stress in Immature as Compared to Mature Male Mice
1997
Depressive Behavior in Mice Due to Immune Stimulation is Accompanied by Reduced Neural Activity in Brain Regions Involved in Positively Motivated Behavior
2006
An Attenuated Immune Response Is Sufficient to Enhance Cognition in an Alzheimer's Disease Mouse Model Immunized with Amyloid-β Derivatives
2004
Amnesic effects of cycloheximide on two strains of mice with different memory characteristics
1971
A Brief Temporal Gradient of Retrograde Amnesia Independent of Situational Change
1965 Science
Norepinephrine Biosynthesis Inhibition: Effects on Memory in Mice
1971 Science
Recovery from amnesia induced by pre-test injections of monoamine oxidase inhibitors
1974
Adult development of the hippocampal-serotonin system of C57BL/6N mice; analysis of high-affinity uptake of 3H-5HT in slices and synaptosomes
1983
Amnesia Produced by Electroconvulsive Shock or Cycloheximide: Conditions for Recovery
1970 Science
Relationship between Taylor Mas Scores and Group Conformity
1959
Sodium chloride intake of adrenalectomized rats with lateral hypothalamic lesions
1967
Reversal of anisomycin-induced amnesia by the ergot derivative Hydergine
1981
Blocking the apolipoprotein E/amyloid-β interaction as a potential therapeutic approach for Alzheimer's disease
2006
Reversal of cycloheximide-induced amnesia by adrenergic receptor stimulation
1977
Brain cyclic AMP and memory in mice
1982
Different temporal gradients of retrograde amnesia produced by carbon dioxide anesthesia and electroconvulsive shock.
1966
Taylor MAS and group conformity pressure.
1960
Alleviation of anisomycin-induced amnesia by pre-test treatment with lysine-vasopressin
1982
Some characteristics of amnesia induced by FLA-63 an inhibitor of dopamine beta hydroxylase
1977
Recovery of memory following amnesia in the rat and mouse.
1972
Temporal Characteristics of Amnesia induced by Protein Synthesis Inhibitor: Determination by Shock Level
1970 Nature
Characteristics of retrograde amnesia following reactivation of memory in mice
1982
Role of experience in relationship between sodium deficiency and rate of bar pressing for salt.
1967
Sensory feedback in time response of drinking elicited by carbachol in preoptic area of rat.
1966
Dissociation of cycloheximide's effects on activity from its effects on memory
1974